Bionano Genomics Inc (BNGO)

Bionano Genomics Inc Aktie (BNGO) Neueste Nachrichten

Bionano Genomics (BNGO) Q1 2024 Earnings Call Transcript

The Motley Fool

Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress

GlobeNewswire Inc.

Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing

GlobeNewswire Inc.

Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire Inc.

Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics

GlobeNewswire Inc.

Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript

The Motley Fool

Bionano to Present at TD Cowen’s 44th Annual Health Care Conference

GlobeNewswire Inc.

Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024

GlobeNewswire Inc.

Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway

GlobeNewswire Inc.

Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference

GlobeNewswire Inc.

Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications

GlobeNewswire Inc.

Bionano Announces Peer-Reviewed Publication from its Clinical Study Designed to Support OGM as Part of Standard of Care (SOC) in Genetic Disease Testing

GlobeNewswire Inc.

Bionano Announces 2024 Symposium: Four Consecutive Days of OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications

GlobeNewswire Inc.

Is AbCellera Biologics (ABCL) Outperforming Other Medical Stocks This Year?

Zacks Investment Research

International Consortium Publishes Comprehensive Roadmap for the Clinical Implementation of OGM in Hematological Malignancy Applications

GlobeNewswire Inc.

Bionano Announces Significant Upgrades to its Bionano Solve Pipeline and its VIA™ Software for OGM Data Analysis in Constitutional Genetic Disease Research

GlobeNewswire Inc.

Bionano Announces Publication of Largest Prospective Prenatal Study Comparing OGM to Chromosomal Microarray Analysis and Karyotyping

GlobeNewswire Inc.

Bionano Announces Publication Demonstrating Utility of OGM to Assess Genome Integrity of CRISPR-Edited Cells as Part of Gene Therapy Development

GlobeNewswire Inc.

After Plunging -23.84% in 4 Weeks, Here's Why the Trend Might Reverse for Bionano Genomics, Inc. (BNGO)

Zacks Investment Research

Bionano Genomics (BNGO) Q3 2023 Earnings Call Transcript

The Motley Fool

Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress

GlobeNewswire Inc.